Studies aim to test expanded uses for transcatheter aortic valve

02/14/2013 | Forbes

The Society of Thoracic Surgeons and the American College of Cardiology recently have received investigational device exemption approval from the FDA to conduct a clinical study evaluating the use of Edwards Lifesciences' Sapien device in patients who are deemed not eligible for aortic valve surgery. The groups are now pursuing FDA approval for two more studies in hopes of expanding the uses of transcatheter aortic valve replacement.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC